Transcription factors NF-kappaB and AP-1/c-fos in cell response to nocodazole

T V Ivanova1, V N Ivanov, E S Nadezhdina

  • 1Institute of Protein Research, Russian Academy of Sciences, Pushchino, Moscow Region.

Membrane & Cell Biology
|January 31, 2002
PubMed

Insights

Nocodazole activates transcription factor AP-1/c-fos in cultured cells. It also affects NF-kappaB levels, potentially interfering with genome expression and impacting experimental results.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Microtubules play crucial roles in cellular processes.
  • Nocodazole is a known microtubule-depolymerizing agent used in research.
  • Transcription factors regulate gene expression.

Purpose of the Study:

  • To investigate the impact of nocodazole on transcription factors NF-kappaB and AP-1/c-fos.
  • To analyze these effects across different cell lines (CHO-K1, HeLa, and T-cell hybridoma 2B4).

Main Methods:

  • Immunoblotting
  • Immunofluorescence
  • Gel retardation assays

Main Results:

  • Nocodazole rapidly activated transcription factor AP-1/c-fos in all studied cell lines.
  • Effects on NF-kappaB varied: no change in 2B4 cells, transient decrease/increase in p50 subunit in CHO-K1 and HeLa cells.
  • Nocodazole inhibited NF-kappaB degradation and decreased p65 subunit content in CHO-K1 cells.

Conclusions:

  • Nocodazole influences the activity and content of key transcription factors.
  • These alterations suggest nocodazole can interfere with genome expression.
  • Researchers should consider these effects when using nocodazole in experiments.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...